Recap: Castle Biosciences Q4 Earnings

Castle Biosciences CSTL reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Castle Biosciences beat estimated earnings by 81.0%, reporting an EPS of $-0.1 versus an estimate of $-0.54.

Revenue was up $27.78 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.5 which was followed by a 8.0% increase in the share price the next day.

Here's a look at Castle Biosciences's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.76 -1.01 -0.89 -0.84
EPS Actual -0.26 -0.70 -1.10 -0.78
Revenue Estimate 48.52M 43.51M 37.37M 37.16M
Revenue Actual 61.49M 50.14M 42.04M 38.34M

To track all earnings releases for Castle Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!